Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 4Lymphedema 2Depression 2Colorectal Neoplasms 2Breast Neoplasms 2Anxiety Disorders 2Unspecified Adult Solid Tumor, Protocol Specific 1Stress Disorders, Post-Traumatic 1Sedentary Behavior 1Rectal Neoplasms 1Prostatic Neoplasms 1Prostate Adenocarcinoma 1Pain 1Overweight 1Obesity 1Melanoma 1Lung Neoplasms 1Leukemia, Myeloid, Acute 1Leukemia 1Head and Neck Neoplasms 1Fatigue 1Digestive System Neoplasms 1Colonic Neoplasms 1Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

luprolide acetate gel depot 1enzalutamide 1entinostat 1apalutamide 1Triptorelin Pamoate 1Methods 1Leuprolide 1Goserelin 1Educational Status 1Early Intervention, Educational 1Counseling 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Prostate Adenocarcinoma × Methods × Clear all
NCT02168062 2020-07-23

Supportive Therapy in Androgen Deprivation Clinic in Improving Health Outcomes and Managing Side Effects in Patients With Prostate Cancer

University of California, San Francisco

Phase 2 Terminated
57 enrolled 27 charts
Genitourinary

Prostate Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡